Belite Bio, Inc. (BLTE)

Market Closed

17 Jul, 20:00

NASDAQ (CM)

150. 08

-0.59

-0.3916%

5.99B Market Cap

- P/E Ratio

- Div Yield

155,000 Volume

- Eps

$ 150.67

Previous Close

Investors:

DTM

Add Transaction

Day Range

147.71 152.76

Year Range

59.12 200

Want to track BLTE and more in your Portfolio? 🎯

Get Started For Free

Belite Bio, Inc. (BLTE) Q3 2024 Earnings Call Transcript

Belite Bio, Inc. (NASDAQ:BLTE ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Tom Lin - Chairman and Chief Executive Officer Hendrik Scholl - Chief Medical Officer Nathan Mata - Chief Scientific Officer Hao-Yuan Chuang - Chief Financial Officer Conference Call Participants Basma Radwan - Leerink Partners Jennifer Kim – Cantor Yi Chen - H.C. Wainwright Michael Okunewitch - Maxim Group Operator Hello, and thank you for joining us to discuss Belite Bio's Third Quarter 2024 Financial Results.

Seekingalpha | 1 year ago

Belite Bio, Inc (BLTE) Q2 2024 Earnings Call Transcript

Belite Bio, Inc (NASDAQ:BLTE ) Q2 2024 Earnings Conference Call August 12, 2024 4:30 PM ET Company Participants Tom Lin - Chairman and Chief Executive Officer Nathan Mata - Chief Scientific Officer Hao-Yuan Chuang - Chief Financial Officer Conference Call Participants Basma Radwan - Leerink Partners Jennifer Kim - Cantor Yi Chen - H.C. Wainwright Bruce Jackson - Benchmark Operator Hello, and thank you for joining us to discuss Belite Bio's Second Quarter 2024 Financial Results.

Seekingalpha | 1 year ago

Blog Affiliate Program About Terms Privacy Help Contact Us